Zivo Bioscience Warrants Stock Beta
ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Zivo Bioscience Warrants fundamentals help investors to digest information that contributes to Zivo Bioscience's financial success or failures. It also enables traders to predict the movement of Zivo Stock. The fundamental analysis module provides a way to measure Zivo Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zivo Bioscience stock.
Zivo |
Zivo Bioscience Warrants Company Beta Analysis
Zivo Bioscience's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Zivo Bioscience Beta | 0.24 |
Most of Zivo Bioscience's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience Warrants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Zivo Bioscience Warrants has a Beta of 0.242. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Zivo Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in beta category among its peers.
As returns on the market increase, Zivo Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zivo Bioscience is expected to be smaller as well.
Zivo Fundamentals
Return On Equity | -39.56 | ||||
Return On Asset | -1.65 | ||||
Operating Margin | (133.25) % | ||||
Number Of Shares Shorted | 5.63 K | ||||
EBITDA | (8.73 M) | ||||
Net Income | (8.75 M) | ||||
Total Debt | 445.18 K | ||||
Cash Flow From Operations | (7.1 M) | ||||
Beta | 0.24 | ||||
Market Capitalization | 35.33 M | ||||
Total Asset | 2.12 M | ||||
Retained Earnings | (115.8 M) | ||||
Working Capital | (126.04 K) | ||||
Z Score | -42.4 | ||||
Net Asset | 2.12 M |
About Zivo Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zivo Bioscience Warrants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience Warrants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Valuation Check real value of public entities based on technical and fundamental data |